Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Sifat Sharmin et al.|JAMA Neurology|2023Cited by 62
Patterns and predictors of multiple sclerosis phenotype transitionLuigi Pontieri, Melinda Magyari, Nupur Greene et al.|Brain Communications|2024Cited by 8